TGT vs VTVT · P/E 17, rev $51.98B vs rev $36.8M
Target Corporation (TGT) versus vTv Therapeutics Inc (VTVT) — a side-by-side from cached financials, not a winner call.
Target Corporation (TGT) is a discount stores company listed on NYSE. It is led by Michael J. Fiddelke.
vTv Therapeutics Inc (VTVT) is a biotechnology company listed on NASDAQ.
Latest reported TGT revenue for 2026-08-01 was $51.98B. Net income was $2.66B. TGT currently screens at market cap $58.05B and trailing P/E 16.9.
Latest reported VTVT revenue for 2026-06-30 was $36.8M. Net income was $11.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. VTVT currently screens at market cap $133.9M.
TGT currently screens at market cap $58.05B and trailing P/E 16.9. VTVT currently screens at market cap $133.9M.
Not investment advice. Open the TGT and VTVT stock pages for the full models.
Not investment advice.